Iron toxicity: Difference between revisions
Neil.m.young (talk | contribs) No edit summary |
(table creation) |
||
| Line 18: | Line 18: | ||
==Clinical Features== | ==Clinical Features== | ||
{| class="wikitable sortable" | |||
|+ Iron Toxicity Stages | |||
|- | |||
! scope="col" | '''Stage''' | |||
! scope="col" | '''Clinical Effect''' | |||
! scope="col" | '''Time Frame''' | |||
|- | |||
| Stage 1||GI Irritation: n/v, abd Pain, diarrhea||30-60 mins | |||
|- | |||
| Stage 2: Latent||Reduced GI symptoms||6-24 hours | |||
|- | |||
| Stage 3: Shock and Metabolic Acidosis||Metabolic Acidosis, Lactic Acidosis, Dehydration, Coags, Renal Failure||6-72 Hours | |||
|- | |||
| Stage 4: Hepatotox||Hepatic Failure||12-96 hours | |||
|- | |||
| Stage 5: Bowel Obstruction||GI bowel scarring/healing||2-8 weeks | |||
|} | |||
==Work-Up== | ==Work-Up== | ||
Revision as of 16:58, 25 January 2015
Background
- Each 325mg ferrous sulfate tablet contains 65mg of elemental iron
- Toxicity
- Mild: 10-20mg elemental iron/kg
- Moderate: 20-60mg/kg (approx 20-35 tablets)
- Severe: >60mg/kg
- Absence of GI symptoms w/in 6hr of ingestion excludes significant iron ingestion
Pathophysiology
- GI tract irritant:
- N/V, diarrhea, abdominal pain, bleeding
- Electron transport chain disruption:
- Lactic acidosis
- Portal vein iron delivery to liver:
- Hepatotoxicity
- Thrombin formation inhibition:
- Coagulopathy
Clinical Features
| Stage | Clinical Effect | Time Frame |
|---|---|---|
| Stage 1 | GI Irritation: n/v, abd Pain, diarrhea | 30-60 mins |
| Stage 2: Latent | Reduced GI symptoms | 6-24 hours |
| Stage 3: Shock and Metabolic Acidosis | Metabolic Acidosis, Lactic Acidosis, Dehydration, Coags, Renal Failure | 6-72 Hours |
| Stage 4: Hepatotox | Hepatic Failure | 12-96 hours |
| Stage 5: Bowel Obstruction | GI bowel scarring/healing | 2-8 weeks |
Work-Up
- CBC
- Chemistry
- Anion gap metabolic acidosis
- Hyperglycemia
- Coags
- LFTs
- Iron levels
- UA
- Used to follow efficacy of Fe chelation (urine changes from rusty color to clear)
- T&S
- In ambiguous cases consider abd xray as most Fe tabs are radioopague
Diagnosis
- Serum Iron Concentration
- Interpret w/ caution: low serum iron levels do not necessarily mean absence of toxicity
- Levels
- <300: nontoxic or mild
- 300-500: Significant GI symptoms and potential for systemic toxicity
- >500: Moderate to severe systemic toxicity
- >1000: severe systemic toxicity and increased morbidity
Treatment
- Asymptomatic pt w/ ingestion of <20mg/kg only requires observation x6hr
- Volume resuscitation
- GI decontamination
- Consider only for large overdose w/ visible pills in the stomach on x-ray
- Whole-bowel irrigation (polyethylene glycol)
- Children: 250-500mL/hr
- Adults: 2L/hr
- Orogastric lavage
- Whole-bowel irrigation (polyethylene glycol)
- Charcoal is not effective
- Consider only for large overdose w/ visible pills in the stomach on x-ray
- Deferoxamine
- Indications:
- Systemic toxicity
- Metabolic acidosis
- Progressive symptoms
- Serum iron level >500
- Dosing:
- 1000mg IV; start at 5mg/kg/hr, increase up to 15mg/kg/hr as tolerated
- Subsequent doses are 500mg increments guided by clinical status of pt / urine color
- Recommended amount during first 24hr is 360mg/kg or 6gm
- Side effects:
- Hypotension (pre-existing hypotension is NOT a contraindication to therapy)
- Contraindicated in renal failure patients not on HD
- Long-term use: mucor/yersenia/mucosal infections, renal failure, sepsis
- Can see "vin rose" urine
- Indications:
- Other therapies
- Dialysis (removes deferoxamine-iron complex in renal failure pts)
- Exchange transfusion
Disposition
- Discharge after 6hr obs for asymptomatic (or only vomited 1-2x) AND ingestion <20mg/kg
- Admit to ICU if deferoxamine required
See Also
Source
- Tintinalli
